The Korea Economic Federation has sent the Ministry of Science and ICT 19 proposed fixes to the AI Basic Act. The headline ask: treat AI that staff use only inside a company differently from services sold to outsiders. The law has been in force since Jan. 22, 2026.
Can affiliates share one company's AI?
KEF says it is unclear whether AI business-operator duties apply when a company shares an AI it built itself with employees or affiliates. It wants general in-house AI that is not high-impact separated from external services, and joint use among affiliates that meet security and management requirements recognised as internal work.
Whoever changes the use carries the risk
If another company turns a general AI into a high-impact use that affects human safety, KEF argues the company that changed the use should carry the risk-management duty. It points to the EU AI Act, which sets similar duties.
Drug and device R&D tools: leave them out
KEF proposes listing preclinical toxicity prediction, coding support for medical-device development and research data analysis as examples excluded from high-impact rules, plus a one-stop window to confirm agency judgments quickly.
Nineteen tasks, five areas
The areas are scope of regulation, disclosure and labeling duties, high-performance and high-impact AI rules, training-data standards and predictability of regulatory expansion. KEF also wants the still-unfinalized safety notices on high-impact AI risk management, user protection and high-performance AI settled soon.
Kwon Hyeok-min, head of KEF's Growth Strategy Division, said obligations should match actual AI risk and each company's role so firms can focus on safe use and innovation.
